Search

Nucleic Acid Labeling Market

Nucleic Acid Labeling Market Size by Product Type (Reagents & Kits, Services), Application (Microarray, Blotting, FISH, In Situ Hybridization, DNA Sequencing, PCR), End User, Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2021 to 2028

Base Year: 2020 Historical Data: 2018-19
  • Report ID: TBI-12547
  • Published Date: Oct, 2021
  • Pages: 239
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

Global nucleic acid labeling market is expected to reach USD 3.65 billion by 2028, at a CAGR of -2.09% from 2021 to 2028. Global Nucleic Acid Labeling market is witnessing a considerable growth owing to rising genomic and enzymology research.

Market Overview:

Nucleic Acid is a complex molecule which carries genetic information from one generation to another. Two main type of Nucleic Acid are RNA and DNA. DNA stands for deoxyribonucleic acid. This is the master blueprint for life and carries genetic material for all free-living organism. RNA stands for Ribonucleic acid; this is found in all living organism and involves in the generation of protein. Nucleic Acid can be easily labelled with many tags, that could help in detection or purification. There are many methods for the labelling of Nucleic Acid such as bioconjugation method, where nucleic acid is attached to other surfaces. The chemical and enzymatic methods generates Nucleic Acid labelled at 5’ or 3’ end. For small scale probe generation enzymatic method is most economical, whereas for large scale probe generation chemical method is most appropriate. The periodate oxidation of RNA is a very common chemical method for the labelling of nucleic acid. Random chemical labelling is another labelling method. In the enzymatic methods for nucleic acid labelling, the enzymes form the nucleic acid probes by randomly taking the modified nucleotides during DNA replications. The labelling can be used in many application which includes DNA sequencing, FISH, situ hybridization. It is also used in microarrays, blotting etc. The rise in the health care infrastructure in the developing countries, the improvement in the diagnostic of diseases with the advancement in technologies and the government initiatives are some of the factors that are driving the Nucleic Acid labelling market. The increasing awareness about the health in the people along with increasing disposable income in the developing countries would lead to an increase in healthcare infrastructure. This will provide a great opportunity for the market in the forecasting period. However, a lack of skilled professionals and cut-throat competition would act as a restraint for the market.

Get an overview of this study by requesting a free sample

Market Dynamics:

Drivers:

  • Rising genomic and enzymology research

The increasing investment and research on genomic and enzymology using protein families and genome context are leading to new discoveries of functionality. This gives more precise information on enzyme mechanism and its functionality, giving more details of its working. This is driving the nucleic acid labelling market. This has wide applications in the life sciences industry.

  • Increasing health care expenditure& improvements in disease diagnostics

There is an increase in disposable income of the people in developed and developing countries which has led to increase in healthcare expenditure and also with the advancement in technology there is a major improvement in the diagnostics of disease. The rise in genomic research and enzymology research has discovered new functions and explained better the functions of enzymes and its evolution, giving a more precise picture of it, is driving this market.

Restraints:
  • Lack of skilled professionals

There is a substantial growth for the Nucleic Acid labeling market. But because of its high cost and complex technologies, it is difficult to find skilled professionals. This factor is acting as the restraint for the market.

Opportunities:
  • The developing economies may provide new growth opportunities

The increasing disposable income in developing economies along with better infrastructure in terms of transport, healthcare facility etc. act as better opportunities for the growth of this market. The surge in disposable income of the people have now given them access for the quality of life, better facilities and also quality products and services. Moreover, in developing economies, the healthcare infrastructure has also gone up. With more access of quality things, people are looking for better healthcare facilities, which created the demand for more genomic and enzymology research so that the healthcare organization can provide better facilities and services. Thou the cost is high, but with the increase in disposable income, people have now access for those quality costly healthcare treatment and services.

Segmentation Analysis:

The global nucleic acid labeling market has been segmented based on product type, application, end user and regions.

  • Product type segment include Reagents & Kits and Services. The reagents & kits and services segment is accounted for the highest market share of 54.25% in 2020. This is because it is widely used in many diagnostic centers and for research purpose. The increase of investment in R&D by big players are also fuelling this segment to have the highest market share.
  • The application segment includes Microarray, Blotting, FISH, In Situ Hybridization, DNA Sequencing, PCR and Others. PCR segment accounted for the largest market share in 2020 of around 80.18%. It is widely used in the study and identification of genetic disorders. The big players are collaborating and also investing in R&D is also the factor that is fuelling this segment.
  • The end-user segment includes Diagnostic Centers, Research Centers and Hospitals. Research centres segment is accounted for the highest market share of around 37.20% in 2020. This is due to the government encouragement and initiatives for the R &D to come up with better drugs and solutions to cure the disease. Also, the big players are collaborating and also investing in R&D is also the factor that is fuelling this segment.
Regional Segmentation Analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and the Middle East and Africa. North America region is accounted for the highest market share of 43.35% in 2020.

  • North America captured a sizeable share of the regional Nucleic Acid Labeling vertical with a share of over 43.35%, due to increase in identifying the genetic modifications, customized medicines, rise in R &D, increase in genomics research, and therapeutic areas are the features contributing the growth of market.
  • Asia-Pacific regional segment seems to have the highest CAGR of 10.1% in the forecasting period. Developing nations such as China and India are likely to witness high growth owing it to the untapped market potential offered by Nucleic Acid Labeling Market.

The North America Nucleic Acid Labeling Market Share in 2020- 43.35%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Competitive Analysis:

The key players are now concentrating on implementing strategies such as adopting new technology, product innovations, mergers & acquisitions, joint venture, alliances and partnerships to improve their market position in the global Nucleic Acid Labeling industry.

For instance, Agilent’s Next Generation Sequencing (NGS) automation solutions support analysts in increasing sample preparation throughput without impacting data quality.

List of Key Market Players:

  • Merck & Co., Inc.
  • PerkinElmer, Inc.
  • New England Biolabs
  • F. Hoffmann La-Roche AG
  • Enzo Biochem
  • General Electric Company
  • Vector Laboratories
  • Promega Corporation
  • Agilent Technologies
  • Thermo Fisher Scientific, Inc
  • NanoView Biosciences Inc

Key Target Audience

  • Hospitals
  • Clinics
  • Government Authorities
  • Research Organization

Report Description:

  • Global Nucleic Acid Labeling Market, Industry Analysis, Trends, Analysis and Forecast, 2021 to 2028 is a forthcoming/imminent research report which is to be published by The Brainy Insights.
  • 2020 is considered as the base year of the report. 2018 and 2019 are considered as the historic years and 2021 to 2028 are the forecast years. The global Nucleic Acid Labeling market is based on revenue (USD Million/Billion), volume and price. The report incorporates the market study on the basis of revenue, and volume. The study covers the market share revenue/market share/volume for each of the segments, regions and countries catering to global Nucleic Acid Labeling market. The regions analyzed for the market are Europe, Asia Pacific, North America, South America and Middle East & Africa. Furthermore, the regions are further analyzed at the country level.
  • The report encompasses with the relative data & information, which have been validated by the leading industry professionals and experts all across the globe. The research report also delivers an outline of the attractiveness of product type, application, end user and regions which are deduced and formulated on the basis of their growth rate (CAGR), market size, and attractiveness by analyzing the present and future prospects to fathom market growth and development in future.
  • The report illustrates the detailed (both quantitative and qualitative) analysis of historical data, revenues, key developments, along with the crucial strategies adopted by key organizations catering to global Nucleic Acid Labeling market.  This offers vital and in depth insights in order to depict the overall market scenario.
  • The report offers the detailed study for the company profiles of key organizations operating in the global Nucleic Acid Labeling market and a comparative assessment based on their product offering, business overviews, geographic presence, business strategies, segment market share, product development & innovations, recent developments, joint venture, partnerships, mergers & acquisitions, strategic alliances, SWOT analysis, and key financial information. This helps in evaluating the overall competition present in the market scenario. 
  • The report provides an elaborative assessment of the porter’s five forces analysis coupled with SWOT analysis so as to provide business related data and information’s. Porter’s five forces model is analyzed to understand the overall competitive scenario that is prevailing in the market. Additionally, the SWOT analysis identifies both the positive and negative attributes of the market development which influences the company growth and development in order to sustain and survive in the long run.
  • Along with that, the report also focuses on the market related driving factors, growth limitations (restraints), potential industry opportunities, significant trends and development which acts as a key potential for the investors. 
  • Potential growth prospects along with the penetration rate analysis of the products (market related i.e., global Nucleic Acid Labeling market) is covered in order to comprehend the adoption rate and evaluate the market size. 

Frequesntly Asked Questions

As per The Brainy Insights, the size of the nucleic acid labeling market was valued at USD 6.97 billion in 2020 and is anticipated to reach USD 3.65 billion by 2028.

Global nucleic acid labeling market is growing at a CAGR of -2.09% during the forecast period 2021-2028.

The global nucleic acid labeling market has been segmented based on product type, application, end user and regions. DNA sequencing segment accounted for the largest market share in 2020.

The North America region emerged as the largest market for the nucleic acid labeling.

Rising genomic and enzymology research is the key driving factor for the nucleic acid labeling market.

Lack of skilled professionals is likely to hamper the market growth.

The developing economies will provide huge opportunities to the market.

Key players are Merck & Co., Inc., PerkinElmer, Inc., New England Biolabs, F. Hoffmann La-Roche AG, Enzo Biochem, General Electric Company.

Get Your Report Customized

  • Further segmentation of the market on the basis of type, application, end use, product, technology, method, process and any other segment depending on the market
  • Segmentation on the basis of any specific country or region
  • Any segment can be classified on the basis of application
  • Application segment can be further divided on the basis of companies
  • The companies profiled are not limited, we can incorporate additional companies of your choice
  • We can split the company market share on the basis of product, application and region
  • Report can be prepared for any specific country/region/segment
  • Customers can be added on the basis of regions and countries
Request for Customization

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis By Product Type
          4.3.2. Market Attractiveness Analysis By Application
          4.3.3. Market Attractiveness Analysis By End User
          4.3.4. Market Attractiveness Analysis By Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Rising genomic and enzymology research
          5.2.2. Increasing health care expenditure & improvements in disease diagnostics
    5.3. Restraints
          5.3.1. Lack of skilled professionals
    5.4. Opportunities
          5.4.1. The developing economies may provide new growth opportunities

6. Global Nucleic Acid Labeling Market Analysis and Forecast, By Product Type
    6.1. Segment Overview
    6.2. Reagents & Kits
    6.3. Services

7. Global Nucleic Acid Labeling Market Analysis and Forecast, By Application
    7.1. Segment Overview
    7.2. Microarray
    7.3. Blotting
    7.4. Fish
    7.5. In Situ Hybridization
    7.6. DNA Sequencing
    7.7. Pcr
    7.8. Others

8. Global Nucleic Acid Labeling Market Analysis and Forecast, By End User
    8.1. Segment Overview
    8.2. Diagnostic Centers
    8.3. Research Centers
    8.4. Hospitals

9. Global Nucleic Acid Labeling MarketAnalysis and Forecast, By Regional Analysis
    9.1. Segment Overview
    9.2. North America
          9.2.1. U.S.
          9.2.2. Canada
          9.2.3. Mexico
    9.3. Europe
          9.3.1. Germany
          9.3.2. France
          9.3.3. U.K.
          9.3.4. Italy
          9.3.5. Spain
    9.4. Asia-Pacific
          9.4.1. Japan
          9.4.2. China
          9.4.3. India
    9.5. South America
          9.5.1. Brazil
    9.6. Middle East and Africa
          9.6.1. UAE
          9.6.2. South Africa

10. Global Nucleic Acid Labeling Market-Competitive Landscape
    10.1. Overview
    10.2. Market Share of Key Players in GlobalNucleic Acid Labeling Market
          10.2.1. Global Company Market Share
          10.2.2. North America Company Market Share
          10.2.3. Europe Company Market Share
          10.2.4. APAC Company Market Share
    10.3. Competitive Situations and Trends
          10.3.1. Product Launches and Developments
          10.3.2. Partnerships, Collaborations, and Agreements
          10.3.3. Mergers & Acquisitions
          10.3.4. Expansions

11. Company Profiles
    11.1. Merck & Co., Inc.
          11.1.1. Business Overview
          11.1.2. Company Snapshot
          11.1.3. Company Market Share Analysis
          11.1.4. Company Product Portfolio
          11.1.5. Recent Developments
          11.1.6. SWOT Analysis
    11.2. PerkinElmer, Inc.
          11.2.1. Business Overview
          11.2.2. Company Snapshot
          11.2.3. Company Market Share Analysis
          11.2.4. Company Product Portfolio
          11.2.5. Recent Developments
          11.2.6. SWOT Analysis
    11.3. New England Biolabs
          11.3.1. Business Overview
          11.3.2. Company Snapshot
          11.3.3. Company Market Share Analysis
          11.3.4. Company Product Portfolio
          11.3.5. Recent Developments
          11.3.6. SWOT Analysis
    11.4. F. Hoffmann La-Roche AG
          11.4.1. Business Overview
          11.4.2. Company Snapshot
          11.4.3. Company Market Share Analysis
          11.4.4. Company Product Portfolio
          11.4.5. Recent Developments
          11.4.6. SWOT Analysis
    11.5. Enzo Biochem
          11.5.1. Business Overview
          11.5.2. Company Snapshot
          11.5.3. Company Market Share Analysis
          11.5.4. Company Product Portfolio
          11.5.5. Recent Developments
          11.5.6. SWOT Analysis
    11.6. General Electric Company
          11.6.1. Business Overview
          11.6.2. Company Snapshot
          11.6.3. Company Market Share Analysis
          11.6.4. Company Product Portfolio
          11.6.5. Recent Developments
          11.6.6. SWOT Analysis
    11.7. Vector Laboratories
          11.7.1. Business Overview
          11.7.2. Company Snapshot
          11.7.3. Company Market Share Analysis
          11.7.4. Company Product Portfolio
          11.7.5. Recent Developments
          11.7.6. SWOT Analysis
    11.8. Promega Corporation
          11.8.1. Business Overview
          11.8.2. Company Snapshot
          11.8.3. Company Market Share Analysis
          11.8.4. Company Product Portfolio
          11.8.5. Recent Developments
          11.8.6. SWOT Analysis
    11.9. Agilent Technologies
          11.9.1. Business Overview
          11.9.2. Company Snapshot
          11.9.3. Company Market Share Analysis
          11.9.4. Company Product Portfolio
          11.9.5. Recent Developments
          11.9.6. SWOT Analysis
    11.10. Thermo Fisher Scientific, Inc
          11.10.1. Business Overview
          11.10.2. Company Snapshot
          11.10.3. Company Market Share Analysis
          11.10.4. Company Product Portfolio
          11.10.5. Recent Developments
          11.10.6. SWOT Analysis
    11.11. NanoView Biosciences Inc
          11.11.1. Business Overview
          11.11.2. Company Snapshot
          11.11.3. Company Market Share Analysis
          11.11.4. Company Product Portfolio
          11.11.5. Recent Developments
          11.11.6. SWOT Analysis

List of Table

1.Global Nucleic Acid Labeling Market, By Product Type, 2018-2028  (USD Billion)

2.Global Reagents & KitsNucleic Acid Labeling Market, By Region, 2018-2028  (USD Billion)

3.Global Services Nucleic Acid LabelingMarket, By Region, 2018-2028  (USD Billion)

4.Global Nucleic Acid Labeling Market, By Application, 2018-2028  (USD Billion)

5.Global Microarray, Nucleic Acid Labeling Market, By Region, 2018-2028  (USD Billion)

6.Global Blotting, Nucleic Acid Labeling Market, By Region, 2018-2028  (USD Billion)

7.Global Fish, Nucleic Acid Labeling Market, By Region, 2018-2028  (USD Billion)

8.Global In Situ Hybridization, Nucleic Acid Labeling Market, By Region, 2018-2028  (USD Billion)

9.Global DNA Sequencing, Nucleic Acid Labeling Market, By Region, 2018-2028  (USD Billion)

10.Global Pcr, Nucleic Acid Labeling Market, By Region, 2018-2028  (USD Billion)

11.Global Others, Nucleic Acid Labeling Market, By Region, 2018-2028  (USD Billion)

12.Global Nucleic Acid Labeling Market, By End User, 2018-2028  (USD Billion)

13.Global Diagnostic Centers, Nucleic Acid Labeling Market, By Region, 2018-2028  (USD Billion)

Global Research Centers, Nucleic Acid Labeling Market, By Region, 2018-2028   (USD Billion)

15.Global Hospitals, Nucleic Acid Labeling Market, By Region, 2018-2028  (USD Billion)

16.Global Nucleic Acid Labeling Market, By Region, 2018-2028  (USD Billion)

17.Global Nucleic Acid Labeling Market, By North America, 2018-2028  (USD Billion)

18.North America Nucleic Acid Labeling Market, By Product Type, 2018-2028  (USD Billion)

19.North America Nucleic Acid Labeling Market, By Application, 2018-2028  (USD Billion)

20.North America Nucleic Acid Labeling Market, By End User, 2018-2028  (USD Billion)

21.U.S. Nucleic Acid Labeling Market, By Product Type, 2018-2028  (USD Billion)

22.U.S. Nucleic Acid Labeling Market, By Application, 2018-2028  (USD Billion)

23.U.S.Nucleic Acid Labeling Market, By End User, 2018-2028  (USD Billion)

24.Canada Nucleic Acid Labeling Market, By Product Type, 2018-2028  (USD Billion)

25.Canada Nucleic Acid Labeling Market, By Application, 2018-2028  (USD Billion)

26.CanadaNucleic Acid Labeling Market, By End User, 2018-2028  (USD Billion)

27.Mexico Nucleic Acid Labeling Market, By Product Type, 2018-2028  (USD Billion)

28.Mexico Nucleic Acid Labeling Market, By Application, 2018-2028  (USD Billion)

29.MexicoNucleic Acid Labeling Market, By End User, 2018-2028  (USD Billion)

30.Europe Nucleic Acid Labeling Market, By Product Type, 2018-2028  (USD Billion)

31.Europe Nucleic Acid Labeling Market, By Application, 2018-2028  (USD Billion)

32.EuropeNucleic Acid Labeling Market, By End User, 2018-2028  (USD Billion)

33.Germany Nucleic Acid Labeling Market, By Product Type, 2018-2028  (USD Billion)

34.Germany Nucleic Acid Labeling Market, By Application, 2018-2028  (USD Billion)

35.GermanyNucleic Acid Labeling Market, By End User, 2018-2028  (USD Billion)

36.France Nucleic Acid Labeling Market, By Product Type, 2018-2028  (USD Billion)

37.France Nucleic Acid Labeling Market, By Application, 2018-2028  (USD Billion)

38.FranceNucleic Acid Labeling Market, By End User, 2018-2028  (USD Billion)

39.U.K. Nucleic Acid Labeling Market, By Product Type, 2018-2028  (USD Billion)

40.U.K. Nucleic Acid Labeling Market, By Application, 2018-2028  (USD Billion)

41.U.K.Nucleic Acid Labeling Market, By End User, 2018-2028  (USD Billion)

42.Italy Nucleic Acid Labeling Market, By Product Type, 2018-2028  (USD Billion)

43.Italy Nucleic Acid Labeling Market, By Application, 2018-2028  (USD Billion)

44.ItalyNucleic Acid Labeling Market, By End User, 2018-2028  (USD Billion)

45.Spain Nucleic Acid Labeling Market, By Product Type, 2018-2028  (USD Billion)

46.Spain Nucleic Acid Labeling Market, By Application, 2018-2028  (USD Billion)

47.SpainNucleic Acid Labeling Market, By End User, 2018-2028  (USD Billion)

48.Asia Pacific Nucleic Acid Labeling Market, By Product Type, 2018-2028  (USD Billion)

49.Asia Pacific Nucleic Acid Labeling Market, By Application, 2018-2028  (USD Billion)

50.Asia PacificNucleic Acid Labeling Market, By End User, 2018-2028  (USD Billion)

51.Japan Nucleic Acid Labeling Market, By Product Type, 2018-2028  (USD Billion)

52.Japan Nucleic Acid Labeling Market, By Application, 2018-2028  (USD Billion)

53.JapanNucleic Acid Labeling Market, By End User, 2018-2028  (USD Billion)

54.China Nucleic Acid Labeling Market, By Product Type, 2018-2028  (USD Billion)

55.China Nucleic Acid Labeling Market, By Application, 2018-2028  (USD Billion)

56.ChinaNucleic Acid Labeling Market, By End User, 2018-2028  (USD Billion)

57.India Nucleic Acid Labeling Market, By Product Type, 2018-2028  (USD Billion)

58.India Nucleic Acid Labeling Market, By Application, 2018-2028  (USD Billion)

59.IndiaNucleic Acid Labeling Market, By End User, 2018-2028  (USD Billion)

60.South America Nucleic Acid Labeling Market, By Product Type, 2018-2028  (USD Billion)

61.South America Nucleic Acid Labeling Market, By Application, 2018-2028  (USD Billion)

62.South America Nucleic Acid Labeling Market, By End User, 2018-2028  (USD Billion)

63.Brazil Nucleic Acid Labeling Market, By Product Type, 2018-2028  (USD Billion)

64.Brazil Nucleic Acid Labeling Market, By Application, 2018-2028  (USD Billion)

65.BrazilNucleic Acid Labeling Market, By End User, 2018-2028  (USD Billion)

66.Middle East and Africa Nucleic Acid Labeling Market, By Product Type, 2018-2028  (USD Billion)

67.Middle East and Africa Nucleic Acid Labeling Market, By Application, 2018-2028  (USD Billion)

68.Middle EastNucleic Acid Labeling Market, By End User, 2018-2028  (USD Billion)

69.UAE Nucleic Acid Labeling Market, By Product Type, 2018-2028  (USD Billion)

70.UAE Nucleic Acid Labeling Market, By Application, 2018-2028  (USD Billion)

71.UAENucleic Acid Labeling Market, By End User, 2018-2028  (USD Billion)

72.South Africa Nucleic Acid Labeling Market, By Product Type, 2018-2028  (USD Billion)

73.South Africa Nucleic Acid Labeling Market, By Application, 2018-2028  (USD Billion)

74.South Africa Nucleic Acid Labeling Market, By End User, 2018-2028  (USD Billion)

List of Figures 

1.Global Nucleic Acid Labeling Market Segmentation

2.Nucleic Acid Labeling Market: Research Methodology

3.Market Size Estimation Methodology: Bottom-Up Approach

4.Market Size Estimation Methodology: Top-Down Approach

5.Data Triangulation

6.Porter’s Five Forces Analysis

7.Value Chain Analysis

8.Global Nucleic Acid Labeling Market Attractiveness Analysis By Product Type

9.Global Nucleic Acid Labeling Market Attractiveness Analysis By Application

10.Global Nucleic Acid Labeling Market Attractiveness Analysis By End User

11.Global Nucleic Acid Labeling Market Attractiveness Analysis By Region

12.Global Nucleic Acid Labeling Market: Dynamics

13.Global Nucleic Acid Labeling Market Share By Product Type(2021 & 2028  )

14.Global Nucleic Acid Labeling Market Share by Application(2021 & 2028  )

15.Global Nucleic Acid Labeling Market Share by End User(2021 & 2028  )

16.Global Nucleic Acid Labeling Market Share by Regions (2021 & 2028  )

17.Global Nucleic Acid Labeling Market Share by Company (2020)

This study forecasts revenue at global, regional, and country levels from 2018 to 2028. The Brainy Insights has segmented the global Nucleic Acid Labelingmarket on the basis of below mentioned segments:

Global Nucleic Acid Labeling Market by Product Type:

  • Reagents & Kits
  • Services

Global Nucleic Acid Labeling Market by Application:

  • Microarray
  • Blotting
  • FISH
  • In Situ Hybridization
  • DNA Sequencing
  • PCR
  • Others

Global Nucleic Acid Labeling Market by End User:

  • Diagnostic Centers
  • Research Centers
  • Hospitals

Global Nucleic Acid Labeling Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Ask for customization Request Sample Speak to analyst Inquire before buying

Flexible Purchase Options

  • Chapters of your choice
  • Quantitative Information for Historical & Forecasted Data
  • Regional/Country Level Reports
Request for Special Pricing

Get in touch with us

+1-315-215-1633

sales@thebrainyinsights.com

Our Clients

Why choose us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date